320 related articles for article (PubMed ID: 8120858)
1. Oral contraceptives for the prevention of osteoporosis.
Corson SL
J Reprod Med; 1993 Dec; 38(12 Suppl):1015-20. PubMed ID: 8120858
[TBL] [Abstract][Full Text] [Related]
2. Rational use of oral contraceptives in the perimenopausal woman.
Connell EB
J Reprod Med; 1993 Dec; 38(12 Suppl):1036-40. PubMed ID: 8120861
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise.
Seeman E; Szmukler GI; Formica C; Tsalamandris C; Mestrovic R
J Bone Miner Res; 1992 Dec; 7(12):1467-74. PubMed ID: 1481732
[TBL] [Abstract][Full Text] [Related]
4. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and history of oral contraceptive use.
Fortney JA; Feldblum PJ; Talmage RV; Zhang J; Godwin SE
J Reprod Med; 1994 Feb; 39(2):105-9. PubMed ID: 8169923
[TBL] [Abstract][Full Text] [Related]
6. Risks of oral contraceptive use in women over 35.
Stenchever MA
J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
[TBL] [Abstract][Full Text] [Related]
7. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
8. Bone-sparing properties of oral contraceptives.
DeCherney A
Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):15-20. PubMed ID: 8571999
[TBL] [Abstract][Full Text] [Related]
9. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group.
Kleerekoper M; Brienza RS; Schultz LR; Johnson CC
Arch Intern Med; 1991 Oct; 151(10):1971-6. PubMed ID: 1929685
[TBL] [Abstract][Full Text] [Related]
11. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
Hannaford PC; Kay CR
Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
[TBL] [Abstract][Full Text] [Related]
12. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes.
Hartard M; Kleinmond C; Kirchbichler A; Jeschke D; Wiseman M; Weissenbacher ER; Felsenberg D; Erben RG
Bone; 2004 Oct; 35(4):836-41. PubMed ID: 15454090
[TBL] [Abstract][Full Text] [Related]
13. Noncontraceptive health benefits and risks of steroidal contraception.
Pasquale SA
Int J Fertil; 1989; 34 Suppl():85-7. PubMed ID: 2576266
[TBL] [Abstract][Full Text] [Related]
14. Noncontraceptive benefits of oral contraceptive use: an evidence-based approach.
Williams JK
Int J Fertil Womens Med; 2000; 45(3):241-7. PubMed ID: 10929688
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
[TBL] [Abstract][Full Text] [Related]
17. Physiologic and pharmacologic effects of estrogen and progestins on bone.
DeCherney A
J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
[TBL] [Abstract][Full Text] [Related]
18. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
Contracept Rep; 1995 May; 6(2):4-9, 14. PubMed ID: 12319497
[TBL] [Abstract][Full Text] [Related]
19. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
20. Consider prescribing OCs for perimenopause use.
Contracept Technol Update; 2000 Mar; 21(3):31-3. PubMed ID: 12349548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
